Published in Virology on September 01, 1999
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines. J Virol (2002) 1.84
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol (2003) 1.79
Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J Virol (2003) 1.68
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol (2006) 1.67
Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One (2008) 1.63
Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J Virol (2005) 1.44
Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. J Virol (2001) 1.44
Replication and partitioning of papillomavirus genomes. Adv Virus Res (2008) 1.21
Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J Virol (2009) 1.17
Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog (2014) 1.16
Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol (2011) 1.15
Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol (2013) 1.11
High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract. Immunology (2006) 1.09
Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol (2007) 1.08
Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology (2010) 1.08
Mechanisms of cell entry by human papillomaviruses: an overview. Virol J (2010) 1.04
Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol (2013) 1.00
Cellular receptor binding and entry of human papillomavirus. Virol J (2010) 0.99
Replication of bovine papillomavirus type 1 (BPV-1) DNA in Saccharomyces cerevisiae following infection with BPV-1 virions. J Virol (2002) 0.97
Concepts of papillomavirus entry into host cells. Curr Opin Virol (2013) 0.93
Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation. J Virol (2001) 0.92
Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol (2012) 0.92
Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions. J Clin Microbiol (2002) 0.91
Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J Virol (2002) 0.91
Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol (2010) 0.90
Palmitoylation by DHHC3 is critical for the function, expression, and stability of integrin α6β4. Cell Mol Life Sci (2012) 0.88
Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection. Virology (2012) 0.87
Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique. Proc Natl Acad Sci U S A (2000) 0.84
Virus interactions with endothelial cell receptors: implications for viral pathogenesis. Curr Opin Virol (2014) 0.84
The role of inflammation in HPV infection of the Oesophagus. BMC Cancer (2013) 0.84
The tetraspanin CD151 in papillomavirus infection. Viruses (2014) 0.81
Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry. PLoS One (2013) 0.80
Study of infectious virus production from HPV18/16 capsid chimeras. Virology (2010) 0.78
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology (1991) 3.28
Genetic polymorphisms and personality in healthy adults: a systematic review and meta-analysis. Mol Psychiatry (2003) 3.07
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol (1997) 2.58
Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J Gen Virol (1993) 2.42
Genetic and environmental causes of variation in basal levels of blood cells. Twin Res (1999) 2.36
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess (2007) 2.10
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry (2006) 2.06
Review of cell and particle trapping in microfluidic systems. Anal Chim Acta (2009) 2.04
Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet (1986) 1.95
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J Virol (1994) 1.83
Transmission of human papillomaviruses from mother to child. Aust N Z J Obstet Gynaecol (1993) 1.63
DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology (1998) 1.33
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess (2006) 1.30
Complicated acute sinusitis. Laryngoscope (1972) 1.29
Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens. J Immunol (1985) 1.25
A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J Clin Microbiol (2000) 1.23
Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein. Virology (1991) 1.21
A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc Natl Acad Sci U S A (1991) 1.19
Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis (1995) 1.16
Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal. Virology (1997) 1.16
Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis (2011) 1.12
HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine (2000) 1.11
Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice. Virology (1998) 1.05
The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology (1992) 1.02
Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. Virology (1996) 1.01
Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK. AIDS Care (2013) 1.00
Nucleotides 1506-1625 of bovine papillomavirus type 1 genome can enhance DNA packaging by L1/L2 capsids. Virology (1999) 1.00
Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. J Gen Virol (1990) 1.00
BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. Virology (2000) 1.00
Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess (2004) 0.98
Association of bovine papillomavirus type 1 with microtubules. Virology (2001) 0.98
Acoustofluidics 5: Building microfluidic acoustic resonators. Lab Chip (2012) 0.96
T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus. Clin Exp Immunol (1982) 0.95
Plasma, blood and extracellular fluid volumes in grazing Hereford cattle. Res Vet Sci (1967) 0.94
Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16. Clin Exp Immunol (1999) 0.94
Genital human papillomavirus infection among patients attending an STD clinic. Genitourin Med (1993) 0.94
Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment. Clin Microbiol Infect (2013) 0.93
Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation. Health Technol Assess (2005) 0.93
Major population differences in T cell response to a malaria sporozoite vaccine candidate. Int Immunol (1990) 0.93
The influence of sexual and social factors on the risk of Chlamydia trachomatis infections: a population-based serologic study. Sex Transm Dis (1996) 0.93
A major quantitative trait locus for CD4-CD8 ratio is located on chromosome 11. Genes Immun (2004) 0.92
The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse. Obstet Gynecol (1994) 0.91
Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH. Clin Exp Immunol (1983) 0.91
Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer? Int J Cancer (1995) 0.91
Pleuroperitoneal effusion without ascites. Med J Aust (1983) 0.91
The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review. Health Technol Assess (2005) 0.90
The silent suffering women--a population based study on the association between reported symptoms and past and present infections of the lower genital tract. Genitourin Med (1995) 0.90
The protective effect of zinc sulphate in experimental sporidesmin poisoning of sheep. N Z Vet J (1977) 0.90
Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine (2001) 0.89
Spontaneous reverse hemolytic plaque formation. III. Monocyte-mediated suppression of elevated plaque formation in autoimmune disease. Clin Immunol Immunopathol (1982) 0.89
Human papillomavirus--a study of male sexual partners. Med J Aust (1988) 0.88
Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins. Vaccine (2000) 0.88
The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha. Virology (2000) 0.88
Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology (1998) 0.88
Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens. Clin Immunol Immunopathol (1985) 0.87
Glycosylation of human papillomavirus type 16 L1 protein. Virology (1993) 0.87
Nonradioisotopic detection and typing of human papillomaviruses by use of polymerase chain reaction and single-strand conformation polymorphism. Diagn Mol Pathol (1996) 0.87
Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter. J Virol (2001) 0.87
Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. J Virol Methods (1993) 0.87
Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.86
Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst (2001) 0.86
Autoantibodies to liver antigens in chronic liver disease. I. A radioimmunoassay for antibody to liver membrane antigens. J Clin Lab Immunol (1982) 0.86
Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies. Virology (1998) 0.85
Male partners of women with genital human papillomavirus infection. An assessment of colposcopic abnormalities by histological examination and human papillomavirus hybridization. Med J Aust (1989) 0.85
Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes. Virology (2000) 0.85
Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame protein. J Immunol (1990) 0.85
'Acute' autoimmune hepatitis. Digestion (1986) 0.85
Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines. J Gen Virol (1994) 0.84
Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model. J Immunol (1998) 0.84
Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Med J Aust (1987) 0.84
Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. Curr Top Microbiol Immunol (1994) 0.83
Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. Virology (1992) 0.83
Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term. Scand J Immunol (1998) 0.83
The use of the fatty acid composition of lipids in the identification of horse and kangaroo meat. J Sci Food Agric (1971) 0.82
An ELISA capture assay for the E7 transforming proteins of HPV16 and HPV18. J Virol Methods (1992) 0.82
Genomewide scans of red cell indices suggest linkage on chromosome 6q23. J Med Genet (2006) 0.82
High-risk human papillomavirus types in cytologically normal cervical scrapes from Kenya. Med Microbiol Immunol (1992) 0.81
Papilloma virus infection of the vulva. Acta Obstet Gynecol Scand (1989) 0.81
Differences in the post-translational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system. Biotechnol Appl Biochem (2000) 0.81
Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years. Q J Med (1986) 0.81
The molecular specificity of linear B-epitopes in the E7 open reading frame protein of human papillomavirus 16 defined by monoclonal antibodies. Pept Res (1992) 0.81
Post translational modifications of recombinant human papillomavirus type 6b major capsid protein. Virus Res (1999) 0.81
E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes. Oncogene (2000) 0.81
The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess (2005) 0.81
Acetowhitening of the cervix and vulva as a predictor of subclinical human papillomavirus infection: sensitivity and specificity in a population-based study. Obstet Gynecol (1997) 0.80
Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol. Arthritis Rheum (1988) 0.80
Feedback path variability modeling for robust hearing aids. J Acoust Soc Am (2000) 0.80
Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis. Clin Exp Immunol (1985) 0.80
Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays. Clin Exp Immunol (1986) 0.79
Lymphocyte ectoenzyme activity compared in healthy persons and patients seropositive to or at high risk of HIV infection. Immunol Cell Biol (1990) 0.79
Serologic response to human papillomavirus 16 among Australian women with high-grade cervical intraepithelial neoplasia. Int J Gynecol Cancer (2006) 0.79
First International Conference on the Acquired Immunodeficiency Syndrome. Med J Aust (1985) 0.79
Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production. Vaccine (1995) 0.79
Antibody to G-actin in different categories of alcoholic liver disease: quantification by an ELISA and significance for alcoholic cirrhosis. Clin Immunol Immunopathol (1985) 0.79
Is infusion phlebitis preventable? Br Med J (1977) 0.79